Table 2.
Metabolic parameters at baseline and 12 months later.
| Parameter | Baseline | 12 months later | p-value |
|---|---|---|---|
| Waist circumference, cm, mean (SD) | 83.58 (10.14) | 102.50 (99.41) | <0.001* |
| Abnormal waist circumference (≥102 cm in men, ≥88 cm in women), n (%) | 6 (10%) | 13 (21.7%) | 0.039* |
| Serum triglycerides, mmol/L, mean (SD) | 0.886 (0.42) | 1.095 (0.75) | 0.042* |
| Abnormal triglyceride concentration (>1.7 mmol/L) or treatment, n (%) | 4 (6.7%) | 6 (10%) | 0.040* |
| Serum HDL-cholesterol (mmol/L), mean (SD) | 1.368 (0.34) | 1.295 (0.31) | 0.028* |
| Abnormally low HDL-cholesterol (<1.04 mmol/L in men, <1.3 mmol/L in women), n (%) | 13 (21.7%) | 15 (25%) | 0.019* |
| Blood pressure (mmHg), mean (SD) | |||
| Systolic | 122.18 (13.50) | 123.17 (13.01) | 0.583 |
| Diastolic | 66.15 (10.16) | 68.02 (9.80) | 0.190 |
| Abnormal blood pressure (≥130/85 mmHg) or treatment, n (%) | 19 (31.7%) | 21 (35.0%) | 0.990 |
| Fasting plasma glucose concentration (mmol/L), mean (SD) | 4.963 (0.77) | 5.014 (0.45) | 0.338 |
| Abnormal fasting blood glucose (≥5.6 mmol/L) or diabetes, n (%) | 3 (5.0%) | 8 (13.3%) | 0.344 |
| MetS, n (%) | 4 (6.7%) | 7 (11.7%) | 0.250 |
| Number of MetS criteria, n (%) | |||
| 0 | 29 (48.3%) | 24 (40%) | |
| 1 | 22 (36.6%) | 20 (33.3%) | |
| 2 | 5 (8.3%) | 9 (15.0%) | |
| 3 | 3 (5.0%) | 5 (8.3%) | |
| 4 | 1 (1.7%) | 2 (3.3%) | |
| 5 | 0 (0%) | 0 (0%) | |
| TG/HDL ratio | 1.48 | 1.94 | |
SD, standard deviation; HDL, high-density lipoprotein; MetS, metabolic syndrome; TG, triglyceride. *p < 0.05. Comparisons of the prevalences of abnormal values of metabolic parameters and MetS were performed using McNemar’s test, and comparisons of mean metabolic and anthropometric values were performed using the Wilcoxon matched-pairs signed rank test.